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Objective: The purpose of this study was to compare peripheral muscle oxygenation in 
persons with chronic obstructive pulmonary disease (COPD) to healthy control persons, during 
submaximal exercise.
Methods: Eight persons with COPD (forced expiratory volume in one second [FEV1] = 1.00 
± 0.27 L) and eight healthy control persons (FEV1 = 1.88 ± 0.55L) performed a submaximal 
graded exercise test (GXT), and completed 4 min of constant load exercise (CON) at 50% of 
peak GXT. Measurements included oxygen uptake, heart rate, arterial oxygen saturation and 
peripheral muscle oxygenation (%StO2) at rest, during exercise, and recovery.
Results: Signiﬁ  cantly greater workloads were attained for controls compared with COPD for 
peak GXT and CON. No signiﬁ  cant differences in %StO2 were observed between groups at: 
rest (GXT: 29.5 ± 22.8 vs 30.4 ± 17.3%; CON: 33.3 ± 15.4 vs 35.1 ± 17.2%); peak GXT (29.4 
± 19.4 vs 26.5 ± 15.9%); 4 min of CON (25.9 ± 13.5 vs 34.5 ± 21.8%); and recovery (GXT: 
46.6 ± 29.1 vs 44.3 ± 21.7%; CON: 40.9 ± 21.5 vs 44.5 ± 23.2%).
Conclusion: These results suggest that peripheral skeletal muscle oxygenation is not com-
promised in COPD during submaximal exercise, and limitations in exercise capacity are most 
likely a result of muscle disuse and poor lung function.
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Introduction
Chronic obstructive pulmonary disease (COPD) is characterized by multiple physiological 
problems such as impaired ventilation and gas exchange, cardiovascular and peripheral 
muscle deconditioning, muscular wasting and weakness, and dypsnea (Sala et al 1999; 
Simon et al 2001; Reusch 2002; Okamoto et al 2003; Saey et al 2003; Richardson et al 
2004). Limitations in ventilation (including airﬂ  ow obstruction, and lung hyperinﬂ  a-
tion leading to mechanical disadvantage of the ventilatory muscles) and gas exchange 
have been considered to be the primary causes of exercise intolerance in COPD (ATS 
and ERS 1999). However, research has recently focused on the limitations in skeletal 
muscle function that may further contribute to exercise intolerance (Richardson et al 
2004). The primary focus of the research on skeletal muscle function in persons with 
COPD has attempted to determine whether the limitations in skeletal muscle function 
are a result of muscle dysfunction associated with COPD pathology, or muscle disuse 
(ATS and ERS 1999).
Studies examining the role of skeletal muscle in the pathophysiology of COPD 
have primarily compared individuals with COPD to control participants who are 
regularly active (Maltais et al 1998; Okamoto et al 2003), or have not utilized a International Journal of COPD 2006:1(4) 468
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control group for comparison purposes (Simon et al 2001; 
Saey et al 2003). Thus, it is difﬁ  cult to assess the effects 
COPD is having on skeletal muscle function. Previous re-
search by Simon and colleagues (2001) demonstrated that 
patients with COPD have limitations in blood ﬂ  ow directed 
to peripheral muscles and that oxygen extraction during 
exercise is limited. This was attributed to a redistribution 
of cardiac output and oxygen from lower limb exercising 
muscles to ventilatory muscles. Casaburi et al (1991), 
Maltias et al (1998), Okamoto et al (2003), and Saey et al 
(2003) have also provided evidence that skeletal muscle 
dysfunction may be responsible for exercise impairment 
through a variety of mechanisms including an early onset 
of lactic acidosis, contractile fatigue, and an impaired 
re-oxygenation of peripheral muscle. In contrast to these 
ﬁ  ndings, Richardson and colleagues (2004) demonstrated 
that the muscle metabolic capacity of persons with COPD 
and healthy, age matched sedentary controls is similar, and 
suggested that muscular mechanical efﬁ  ciency is reduced in 
persons with COPD and may be the primary factor limiting 
skeletal muscle function.
In summary, it is difﬁ  cult to assess if the limitations 
in skeletal muscle function in persons with COPD results 
from muscle dysfunction associated with COPD pathology 
or muscle disuse because control subjects have not been 
closely matched to COPD subjects in previous studies. The 
aim of this study was to further investigate if the limitations 
in skeletal muscle function in persons with COPD results 
from muscle dysfunction associated with COPD pathol-
ogy or muscle disuse. In the present study we compared 
peripheral muscle oxygenation, monitored by near infrared 
spectroscopy (NIRS), during incremental and constant load 
aerobic exercise, in persons with COPD against healthy 
control persons, who were matched by age, weight, and 
gender.
Methods
Participants
Eight persons with COPD and eight healthy age, weight, 
and gender matched-control persons completed this study. 
Although a quantitative assessment of activity levels was not 
done, all subjects were interviewed through personal com-
munications about current activity levels, and we attempted 
to closely match subjects by their verbal description of their 
activity levels. Participants’ activity levels were matched for 
type, duration and intensity of exercise performed, as well 
as activities of daily living that they completed on a day to 
day basis (ie, laundry, vacuuming, grocery shopping). The 
diagnosis of COPD was based on current clinical evaluation 
by the participant’s doctor and from pulmonary function 
testing during participation in the study. Participants were 
not suffering from any acute illness at the time of study and 
were free from any other medical conditions that would 
limit their ability to perform the exercise testing. Participants 
were all nonsmokers at the time of the study with the excep-
tion of one COPD participant. The participant was asked to 
abstain from smoking 24hrs prior to any testing and this was 
conﬁ  rmed verbally with the investigator upon arrival to the 
laboratory. Written informed consent, which was approved 
by the human subjects committee at Florida Agricultural and 
Mechanical University, was obtained from each individual 
prior to participation. 
Incremental exercise testing
Participants visited the laboratory on two separate occasions. 
During the ﬁ  rst visit, participants performed a submaximal 
(~70% of estimated maximal heart rate), symptom-limited, 
graded exercise test (GXT) on an electronically braked cycle 
ergometer (SensorMedics, Ergoline 800STM, Yorba Linda, 
CA). Participants rested quietly for 5 min prior to the start 
of exercise so that baseline resting measurements could 
be obtained. The GXT utilized a ramp protocol, starting 
at 0 W for the 1st min and then increased by 7 W every 
minute thereafter for persons with COPD, and by 15 W for 
control participants. Participants were constantly monitored 
to maintain their cadence between 50–60 rpm. Exercise was 
terminated upon attainment of 70% estimated maximal heart 
rate and participants remained quietly seated for the next 
5 min for the collection of post exercise measurements.
Constant load exercise testing 
During a second visit to the lab, participants performed a 
6 min steady state exercise test (constant load) at 50% of the 
workload obtained during the submaximal GXT. Prior to 
the start of the test, participants rested for 5 min for the de-
termination of resting baseline measurements and then began 
the exercise test. At the start of exercise, participants warmed 
up for 1 min at 0 W. The workload then increased to 25% 
of the workload obtained during the submaximal GXT for 
1 min. Following this 2 min warm-up period, the workload 
was increased to 50% of the workload obtained during the 
submaximal GXT and participants maintained this workload 
for 6 min. Participants were constantly monitored to maintain 
their cadence between 50–60 rpm.International Journal of COPD 2006:1(4) 469
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Oxygen uptake, heart rate and 
dyspnea measures 
Oxygen uptake (VO2) was determined by breath-by-breath 
gas exchange analysis (SensorMedics, Vmax 229TM 
Metabolic Cart System, Yorba Linda, CA). Before each 
exercise test, the ﬂ  ow-volume sensor was calibrated with a 
3-L calibration syringe and gas analyzers were calibrated 
using known gas concentrations. The metabolic data were 
averaged over the ﬁ  nal 20 sec of each minute of collection. 
A 12-lead electrocardiogram (ECG) (Quniton, Q4500TM, 
Bothall, WA) was utilized to continuously monitor heart 
rate (HR) and was supervised by a physician during all test-
ing sessions. Dyspnea was subjectively rated during the last 
10 seconds of each minute of exercise and recovery, using 
a modiﬁ  ed Borg, 0 to 10 scale (Jones 1988).
Peripheral muscle oxygenation and 
arterial oxygenation
Peripheral muscle oxygenation (%StO2) was continuously 
estimated, noninvasively, through NIRS during rest, exercise, 
and recovery periods (Inspectra Tissue Spectrometer Model 
325 System, Hutchinson Technology Inc., Hutchinson, MN). 
The principles of NIRS and the reliability and validity of 
the measurement have been previously described in detail 
(Mancini et al 1994; Austin et al 2005). Brieﬂ  y, the NIRS 
probe was placed on the right vastus lateralis muscle approxi-
mately 14–20 cm from the knee joint. The measurement site 
for each individual was marked with a permanent marker, to 
locate the same placement of the probe for both exercise tests. 
Before each exercise test, the NIRS probe was calibrated 
to known wavelengths equivalent to a StO2 measurement 
of 36 ± 2% and 85 ± 2%, according to the manufacturer’s 
protocol and speciﬁ  cations. The NIRS unit was interfaced 
with a computer and %StO2 data were averaged over the ﬁ  nal 
20 sec of each minute of collection.
Arterial oxygen saturation was continuously estimated 
(%SpO2), during rest, exercise, and recovery periods with 
a pulse oximeter (SensorMedics, StatTrakTM, Yorba Linda, 
CA) and attached to the subject by a ﬁ  nger probe. The pulse 
oximeter was electronically integrated to the SensorMedics, 
Vmax 229TM Metabolic Cart System. The %SpO2 data 
were averaged over the ﬁ  nal 20 sec of each minute of 
collection. 
Pulmonary function testing
During the second visit and prior to exercise, participants com-
pleted a pulmonary function test (SensorMedics, Vmax 229TM 
Metabolic Cart System, Yorba Linda, CA) using standard 
spirometry procedures (ATS 1995) for the determination of 
forced vital capacity (FVC), and forced expiratory volume 
in one second (FEV1). Before each pulmonary function test, 
the ﬂ  ow-volume sensor was calibrated with a 3-L calibration 
syringe. Reference equations from Morris and colleagues 
(1971) were used to derive the subject’s predicted spiro-
metric values.
Statistical analysis 
Independent t-tests were utilized to compare differences 
between groups for measures of the participant physical 
characteristics, and for the measures of workload during GXT 
and constant load exercise. A repeated measures analyses of 
variance (ANOVA; group × time) was utilized to compare 
differences between groups and across time for the measures 
of VO2, HR, %StO2, %SaO2, and dyspnea during the GXT, 
and the constant load exercise test. When interactions or 
main effects were determined to be signiﬁ  cantly different, 
independent t-testing was used to determine which individual 
means were signiﬁ  cantly different. Simple linear regression 
analysis was utilized to examine possible relationships be-
tween %StO2 and VO2, %SaO2, and measures of pulmonary 
function (FEV1, FVC, and %FEV1/FVC), during GXT and 
constant load exercise. A statistical signiﬁ  cance of p ≤ 0.05 
was used for all analyses. 
Results
Physical characteristics of participants
Table 1 presents the descriptive characteristics of the 
participants. Both groups were closely matched in gender, 
age, height, weight, and body mass index (BMI). Persons 
with COPD had signiﬁ  cantly lower FEV1, percent predicted 
FEV1, and %FEV1/FVC values than control participants. 
Persons with COPD were classiﬁ  ed as having moderate to 
severe COPD, based on percent predicted values (Table 1) 
(ATS 1986).
Graded exercise testing
Signiﬁ  cantly greater workloads were attained for control par-
ticipants, compared with persons with COPD, at peak GXT 
(73.8 ± 36.2W vs 36.9 ± 11.9W). Table 2 presents data from 
the GXT. A signiﬁ  cant interaction between groups and time 
was observed for VO2 and HR. Control participants compared 
with persons with COPD, had signiﬁ  cantly greater peak 
VO2 values (12.3 ± 3.5 ml O2*kg–1*min–1 vs 7.9 ± 2.9 ml 
O2*kg–1*min–1) and peak HR values (122 ± 11 beats*min–1 International Journal of COPD 2006:1(4) 470
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vs 110 ± 7 beats*min–1). No signiﬁ  cant differences between 
groups were found for measures of dyspnea.
No signiﬁ  cant differences in %StO2 were observed be-
tween groups (control vs COPD), at rest, peak exercise, or 
during recovery from exercise. A signiﬁ  cant interaction be-
tween groups and time was observed for %SaO2. Signiﬁ  cantly 
higher %SaO2 values for control participants, compared with 
persons with COPD, were found at rest (96.8 ± 1.0% vs 93.5 
± 1.7%) and during min 1 of recovery (96.0 ± 1.3% vs 92.8 
± 2.4%) from exercise.
Constant Load Exercise testing
The eight control participants completed 6 min of constant 
load exercise. Only six COPD participants completed 6 min 
of constant load exercise. Seven COPD participants completed 
5 min of constant load exercise and all eight COPD partici-
pants completed 4 min of constant load exercise. Signiﬁ  cantly 
greater workloads were attained for control participants, com-
pared with persons with COPD, during constant load exercise 
(36.9 ± 18.1W vs 18.1 ± 6.5W). 
Table 3 presents data from the constant load exercise test. 
A signiﬁ  cant interaction between groups and time was observed 
for VO2 and HR. Control participants, compared with persons 
with COPD, had signiﬁ  cantly greater VO2 values at min 4 of 
constant load exercise (9.3 ± 3.6ml O2*kg–1*min–1 vs 6.1 ± 
1.7 ml O2*kg–1*min–1). Control participants, compared with 
persons with COPD, had signiﬁ  cantly lower HR values at 
rest (67 ± 11 beats*min–1 vs 86 ± 8 beats*min–1), and during 
recovery from exercise at min 1 (77 ± 13 beats*min–1 vs 93 
± 12 beats*min–1) and min 5 (72 ± 12 beats*min–1 vs 89 ± 
11 beats*min–1). No signiﬁ  cant differences between groups 
were found for measures of dyspnea.
No significant differences in %StO2 were observed 
between groups (control vs COPD), at rest, constant load 
exercise, or during recovery from exercise. A signiﬁ  cant in-
teraction between groups and time was observed for %SaO2. 
Signiﬁ  cantly higher %SaO2 values for control participants, 
compared with persons with COPD, were found at rest (96.3 
± 1.3% vs 93.6 ± 1.5%), at min 4 of constant load exercise 
(95.8 ± 2.2% vs 92.9 ± 2.2%), and during recovery from 
exercise at min 1 (95.9 ± 2.0% vs 93.4 ± 2.6%) and min 5 
(96.8 ± 0.7% vs 94.9 ± 1.0%).
Table 1 Physical characteristics of participants (N = 16)
  Control (N = 8)  COPD (N = 8)
Gender (N Males [M]/ 
Females [F])  1 M/7 F  1 M/7 F
Age (yr)  67.8 ± 14.5  68.5 ± 11.5
Weight (kg)  75.1 ± 31.8  74.9 ± 31.3
Height (cm)  161.4 ± 5.1  162.1 ± 7.4
BMI (kg*(m2) –1)  28.7 ± 12.0  28.2 ± 10.4
FEV1 (L)  1.88 ± 0.55*  1.00 ± 0.27
Predicted FEV1%  91 ± 24*  51 ± 22
FVC (L)  2.65 ± 0.54  2.36 ± 0.81
FEV1/FVC%  70 ± 12*  44 ± 12
Notes: Values (other than Gender) are mean ± standard deviation; *Signiﬁ  cant 
difference between groups, control versus COPD, p ≤ 0.05).
Abbreviations: COPD, chronic obstructive pulmonary disease; BMI, body mass 
index; FEV1, forced expiratory volume in one second; FVC, forced vital capacity. 
Table 2 Graded exercise test (GXT) (N = 16)
  Rest  Peak GXT  min 1 Recovery  min 5 Recovery
%StO2      
   Control  29.5 ± 22.8  29.4 ± 19.4  48.0 ± 28.9  46.6 ± 29.1
   COPD  30.4 ± 17.3  26.5 ± 15.9  42.6 ± 19.4  44.3 ± 21.7
%SaO2*      
   Control  96.8 ± 1.0δ  94.3 ± 4.0  96.0 ± 1.3δ  96.3 ± 1.3
   COPD  93.5 ± 1.7  91.8 ± 2.8  92.8 ± 2.4  95.1 ± 1.1
VO2 (ml O2*kg–1*min–1)*      
   Control  2.7 ± 0.8  12.3 ± 3.5δ  5.3 ± 1.5  2.5 ± 0.4
   COPD  2.9 ± 1.0  7.9 ± 2.9  5.8 ± 1.8  2.5 ± 0.8
HR (beats*min–1)*      
   Control  76 ± 14  122 ± 11δ  92 ± 21  79 ± 14
   COPD  81 ± 10  110 ± 7  97 ± 13  89 ± 10
Dyspnea (0–10)       
   Control  –  2.4 ± 1.3  0.8 ± 1.2  0.1 ± 0.4
   COPD  –  2.6 ± 0.9  2.0 ± 1.9  0.3 ± 0.4
Notes: Values are mean ± standard deviation; *Signiﬁ  cant interaction between groups and time, p ≤ 0.05; δSigniﬁ  cant difference between groups, control versus COPD, 
p ≤ 0.05; Control participants at all time points, N = 8; COPD participants at all time points, N = 8. 
Abbreviations: COPD, chronic obstructive pulmonary disease; HR, heart rate; min, minute; %SaO2, arterial oxygen saturation; %StO2 , peripheral muscle oxygenation; 
VO2, oxygen uptake.International Journal of COPD 2006:1(4) 471
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Relationships between %StO2 and VO2, 
%SaO2 and measures of pulmonary 
function 
Table 4 shows correlation coefﬁ  cients (r values) between 
%StO2 and VO2, %SaO2 and pulmonary function measures 
(FEV1, FVC, and %FEV1/FVC) during incremental and con-
stant load exercise, in all subjects, at various time points. The 
only signiﬁ  cant correlations observed were between %StO2 
and VO2, at rest, during both GXT (r = 0.60) and constant 
load exercise (r = 0.62). 
Responses of %StO2 during exercise
Differences in the exercise and post-exercise %StO2 measures 
that were demonstrated in both COPD and control participants 
during the GXT and CON tests can be found in Figures 1 
and 2. In most participants (5 COPD, 5 control), no signiﬁ  cant 
change in %StO2 was found from rest to peak exercise load 
during the incremental exercise test or during the constant 
load exercise test (Figure 2). A signiﬁ  cant change in %StO2 
was based on the known standard error of the equipment 
during cycle exercise and placing a 95% conﬁ  dence interval 
around the resting %StO2 value; thus participants had to 
achieve a greater than 8% change in StO2 values. In contrast, 
six participants (3 COPD, 3 control) demonstrated a steady 
decline in %StO2 (Figure 1). The post exercise %StO2 
response was characterized by a rapid re-oxygenation in 
these 6 participants (3 COPD, 3 controls). However, the other 
participants (5 COPD, 5 controls) demonstrated almost no 
change or an increase above resting values in %StO2 follow-
ing the incremental and constant load exercise tests.
Discussion
Prior research examining the causes of exercise intolerance in 
persons with COPD attributed exercise cessation primarily to 
dyspnea and limitations in ventilation and gas exchange that 
limit O2 delivery to the exercising muscle (Maltais et al 1998; 
ATS and ERS 1999; Richardson et al 2004). However, it has 
been demonstrated that patients with similar FEV1 values 
have a wide range of exercise capacity (Jones and Killian 
1991) and that cardiorespiratory ﬁ  tness is partially dependent 
on peripheral muscle function (Maltais et al 1998). Previous 
ﬁ  ndings have also suggested that peripheral muscle weak-
ness in persons with COPD is a result of functional changes 
that have lead to skeletal muscle dysfunction (ATS and ERS 
1999). However, these same observed changes are also found 
in deconditioned muscle and suggest that disuse rather than 
pathological dysfunction is what causes changes in muscle 
Table 3 Constant load exercise
  Rest  min 4  min 5  min 6  min 1  min 5 
    Constant Constant Constant Recovery Recovery
    load load load
    exercise exercise exercise
%StO2        
   Control  33.3 ± 15.4  25.9 ± 13.5  28.9 ± 13.9  28.1 ± 12.8  39.3 ± 18.4  40.9 ± 21.5
   COPD  35.1 ± 17.2  34.5 ± 21.8  35.0 ± 25.5  32.8 ± 27.3  45.4 ± 22.5  44.5 ± 23.2
%SaO2*        
   Control  96.3 ± 1.3δ  95.8 ± 2.2δ  95.4 ± 3.5  95.4 ± 3.4  95.9 ± 2.0δ  96.8 ± 0.7δ
   COPD  93.6 ± 1.5  92.9 ± 2.2  93.3 ± 2.4  93.2 ± 2.8  93.4 ± 2.6  94.9 ± 1.0
VO2 (ml O2*kg–1 *min–1)*        
   Control  2.9 ± 1.0  9.3 ± 3.6δ  9.6 ± 3.8  9.2 ± 3.2  5.0 ± 1.5  2.6 ± 1.1
   COPD  2.6 ± 0.7  6.1 ± 1.7  6.9 ± 1.8  6.4 ± 1.8  4.5 ± 1.2  2.4 ± 0.4
HR (beats*min–1)*       
   Control  67 ± 11δ  97 ± 12  97 ± 12  98 ± 11  77 ± 13δ  72 ± 12δ
   COPD  86 ± 8  104 ± 11  102 ± 12  100 ± 10  93 ± 12  89 ± 11
Dyspnea  (0–10)       
   Control  –  1.9 ± 1.2  2.0 ± 1.2  1.9 ± 1.1  0.5 ± 0.8  0.1 ± 0.2
   COPD  –  1.7 ± 1.1  1.6 ± 1.1  1.9 ± 1.3  1.0 ± 1.6  0.0 ± 0.0
Notes: Values are mean ± standard deviation; *Signiﬁ  cant interaction between groups and time, p ≤ 0.05; δSigniﬁ  cant difference between groups, control versus COPD, 
p ≤ 0.05; Control participants at all time points, N = 9; COPD participants N = 8, at Rest, min 4 Constant Load Exercise, min 1 and min 5 Recovery from exercise; 
COPD participants N = 7, at min 5 Constant Load Exercise; COPD participants N = 6, at min 6 Constant Load Exercise. 
Abbreviations: COPD, chronic obstructive pulmonary disease; HR, heart rate; min, minute; %SaO2, arterial oxygen saturation; %StO2 , peripheral muscle oxygenation; 
VO2, oxygen uptake.International Journal of COPD 2006:1(4) 472
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structure and function (Booth and Gollnick 1983; Larson 
and Ansved 1985).
In the present study we attempted to match our participants 
for age, gender, BMI, and activity levels. Nonetheless, control 
participants had greater lung function and higher exercise 
capacities than the COPD participants as was evidenced by 
the pulmonary function data, VO2 data, exercise workloads, 
and the inability of 2 COPD participants to complete 6 min 
of constant load exercise. Cessation of exercise for the two 
participants that completed only 4 min and 5 min of exercise, 
respectively, at their constant workload, was because of mus-
cular fatigue. However, it is interesting to note that during 
both exercise tests, that there were no signiﬁ  cant differences 
in dyspnea ratings between COPD and control participants. 
Since the Borg rating scale used in this study is a validated 
assessment tool for breathlessness (Killian 1985), we believe 
the results reﬂ  ect that the exercise intensities were relatively 
low. Thus, our ﬁ  ndings are in agreement with previous stud-
ies (Maltais et al 1998; ATS and ERS 1999; Richardson et al 
2004) suggesting that exercise intolerance in COPD may be 
primarily attributed to impaired oxygen delivery associated 
with COPD pathology causing limitations in ventilation 
and gas exchange. Furthermore, in the present study we 
observed that control participants and persons with COPD 
had similar levels of %StO2 during exercise. This suggests 
that COPD pathology does not cause muscle dysfunction 
in terms of impaired muscle oxygenation in persons with 
moderate COPD.
The findings of our study are in agreement with 
Richardson and colleagues (2004) who employed direct 
measurements of oxygen utilization and blood ﬂ  ow in evalu-
ating metabolic capacity in persons with COPD. Despite the 
ﬁ  nding of a greater percentage of Type II ﬁ  bers, structure in 
Table 4 Correlation coefﬁ  cients (r values) between peripheral muscle oxygenation (%StO2) and oxygen uptake (VO2), arterial 
oxygenation (%SaO2) and pulmonary function measures (forced expiratory volume in one second [FEV1], forced vital capacity [FVC], 
and %FEV1/FVC) during incremental (GXT) and constant load exercise, in all subjects (N = 16)
GXT %StO2 – Rest  %StO2 – Peak  %StO2 – min 1   %StO2 – min 5 
   exercise  Recovery  Recovery
VO2 (at same time points)  0.60*  0.18  0.23  0.16
%SaO2 (at same time points)  0.12  0.37  0.07  0.07
FEV1  0.27 0.24  0.07  0.03
FVC  0.32 0.45  0.13  0.15
%FEV1/FVC  0.10 0.04  0.04  0.09
Constant load exercise
 %StO2 – Rest  %StO2 – min 4    %StO2 – min 1   %StO2 – min 5  
   Constant  load  Recovery  Recovery
   exercise
VO2 (at same time points)  0.62*  0.20  0.48  0.31
%SaO2 (at same time points)  0.11  0.15  0.08  0.03
FEV1  0.21 0.39  0.27  0.15
FVC  0.19 0.46  0.20  0.11
%FEV1/FVC  0.15 0.14  0.19  0.13
Notes: *Signiﬁ  cant difference between groups, control versus COPD, p £ 0.05.
Abbreviations: COPD, chronic obstructive pulmonary disease.
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Figure 1 Comparison of deoxygenation in COPD and control participants.
Abbreviations: COPD, chronic obstructive pulmonary disease; StO2, peripheral 
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terms of muscle ﬁ  ber cross sectional area, capillary density 
and mitochondrial volume were not different between COPD 
and controls. Thus, Richardson concluded that limitations in 
exercise capacity were a result of mechanical inefﬁ  ciency 
(ie, work performed per unit of oxygen consumed) due to 
an increase in Type II muscle ﬁ  bers, and that persons with 
COPD do not demonstrate a diminishment in muscle O2 
utilization due to dysfunction. While we did not perform 
assessment of muscle type and structure in the present study, 
the nonsigniﬁ  cant differences observed between the groups 
in measures of %StO2 provide evidence to support the theory 
that muscle disuse leading to inefﬁ  ciency rather than muscle 
dysfunction may further be reducing exercise capacity in 
persons with COPD and sedentary, healthy adults.
Others have also reported that muscle O2 delivery is main-
tained in those with COPD, however impaired O2 utilization 
was reported and muscle dysfunction suggested (Maltais 
et al 1998; Simon et al 2001). Maltais and colleagues have 
shown that peripheral O2 delivery is preserved in persons 
with COPD and that the signiﬁ  cantly greater skeletal muscle 
acidosis observed in these individuals at peak O2 uptake was 
potentially a cause for the early cessation of exercise; thus 
reﬂ  ecting an altered metabolic function of the skeletal muscle 
and indicating dysfunction. 
Several other explanations for the reported disparity 
between supply of muscle oxygen and utilization have been 
proposed; however all have concluded that this indicates mus-
cle dysfunction rather than detraining. Saey and colleagues 
have suggested that exercise tolerance in COPD during 
constant load cycling is dependent on contractile leg fatigue, 
and that differences in fatigue existed between individuals. 
When participants were divided based on fatigability during 
the exercise test, it was found that despite improving FEV1 
through the use of a bronchodilator, that peripheral muscle 
fatigue limited exercise tolerance in those who demonstrated 
early fatigue. Unfortunately a control group was not utilized 
for comparison purposes. 
In a study examining limitations in lower limb oxygen 
consumption of persons with COPD, Simon and colleagues 
(2001) reported that exercise capacity was signiﬁ  cantly 
greater in participants who did not demonstrate a plateau 
in leg oxygen consumption, than in those participants who 
did plateau in leg oxygen consumption despite a continued 
increase in total body oxygen uptake. This was attributed to a 
redistribution of cardiac output O2 from the lower extremities 
to pulmonary musculature in the plateau group. The rationale 
provided for redistribution was in part attributed to a limita-
tion in O2 extraction by peripheral exercising muscle. The 
results of Simon et al (2001) and Saey et al (2001) indicate 
that despite ventilatory limitation, some individuals with 
COPD are additionally limited during whole body cycling 
exercise by the ability of the peripheral musculature to utilize 
oxygen.
An additional study by Okamoto and colleagues (2003) 
which also utilized NIRS to assess peripheral skeletal 
muscle oxygen utilization, reported a signiﬁ  cantly greater 
time for re-oxygenation following submaximal exercise in 
persons with COPD when compared with controls. It was 
additionally found in persons with COPD that a signiﬁ  cant 
positive relationship existed between the time VO2 remained 
elevated during exercise and duration needed for complete 
re-oxygenation of peripheral skeletal muscle. This relation-
ship was not found in the present study. In addition, VO2 and 
%StO2 were not signiﬁ  cantly different between the groups 
at any time point of recovery during the GXT or constant 
load exercise test; however, %SaO2 was signiﬁ  cantly lower 
in COPD than controls during recovery. The discrepancy 
between our study and that of Okamoto and colleagues (2003) 
might be attributed to differences in the control groups that 
were utilized for comparison purposes.
Several differences in the exercise and post-exercise 
%StO2 measures were observed (Figures 1 and 2) for 
the COPD and control participants of the present study. Some 
subjects demonstrated a desaturation response during both 
types of exercise. As noted above, we believe that the exercise 
workloads in this study were likely of relatively low intensity, 
Figure 2 Comparison of no deoxygenation in COPD and control participants.
Abbreviations: COPD, chronic obstructive pulmonary disease; StO2, peripheral 
muscle oxygenation. 
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as indicated by similarities in dyspnea ratings between 
groups. Thus, it is possible that the intensity was not high 
enough to stimulate a desaturation response. However, this 
same phenomena (lack of tissue desaturation) has been 
observed in well trained triathletes, cyclists, and runners 
during high intensity exercise (ie, exercise tests to lactate 
threshold and maximal tests to exhaustion) (Snyder and 
Parmenter 2002; Snyder et al 2003; Austin et al 2005). Thus, 
we believe that the workload intensities were sufﬁ  cient 
for the study purpose, and this lack of tissue desaturation 
response, in some individuals, does occur in healthy sub-
jects, athletes, and persons with COPD at various exercise 
intensities. What other possibilities might explain this 
lack of tissue desaturation response during exercise? van-
Beekvelt and colleagues (2001) have suggested that NIRS 
measurements may be affected by adipose tissue thickness. 
These researchers reported muscle oxygen consumption, 
as measured by NIRS, is negatively correlated (r = –0.70, 
p < 0.01) to adipose tissue thickness, indicating that adi-
pose tissue is a confounding factor in obtaining valid NIRS 
measurements. In the present study we did not measure 
skinfold thickness, thus it is possible that % StO2 read-
ings were skewed because of an excess in adipose tissue 
at the measurement site. However, we found that when we 
compared BMI values with the %StO2 response, those with 
normal BMIs (18.5–24.9) had just as frequent a variation in 
the %StO2 response as did those with overweight or obese 
BMIs (≥ 25.0) (Expert Panel 1998). Austin and colleagues 
(2005) have also reported the same type of varied response 
for %StO2 in well trained athletes who did not appear to 
have large amounts of body adiposity at the measurement 
sites; thus, something in addition to the thickness of adipose 
tissue appears to inﬂ  uence the results obtained by NIRS and 
warrants further investigation.
Impaired muscle oxygen utilization has also been reported 
in persons with insulin resistance, hypertension, cardiovas-
cular disease (CVD), diabetes, and peripheral arterial disease 
(PAD) (Reusch 2002; Bauer et al 2004). Prior literature has 
reported that COPD causes vasoconstriction in the pulmo-
nary vasculature, resulting in pulmonary hypertension (Hida 
et al 2002). Additionally, in COPD there is evidence of an 
impaired endothelial cell release of the vasodilator and nitric 
oxide in the pulmonary vasculature due to atherosclerosis 
(Hida et al 2002). This is also reported for persons with car-
diovascular disease and PAD in the coronary and peripheral 
vasculature due to atherosclerosis (Reusch 2002). While none 
of the participants had known PAD, CVD, or diabetes, it may 
be hypothesized that individuals demonstrating impaired 
muscle oxygen use and without the post-exercise vasodila-
tory response may additionally be suffering from a lack in 
vasodilatory capacity due to impairments of endothelial cell 
release of nitric oxide.
Limitations of the present study
The major limitation of the present study is the small sample 
size which may have prevented us from determining any 
signiﬁ  cant differences in %StO2. We had a large and varied 
response in %StO2 within the COPD and control groups, 
which limits the power of the data. This may be a result of the 
varied activity levels of the COPD and control participants, 
and should be further examined through a larger population 
of exercising and nonexercising persons for both of these 
populations. Additionally, several of our participants were 
taking medications for both hypertension and hyperlipidemia, 
which may contribute to decreases in nitric oxide, and thus 
may have further led to the variance in %StO2 responses that 
were seen in the present study. Further work is needed to 
assess the impact of such medications on peripheral muscle 
oxygenation, along with the effects which could be solely 
attributable to hypertension and hyperlipidemia. Future re-
search that examines the role of peripheral oxygenation in 
persons with COPD should include the assessment of blood 
ﬂ  ow, hemoglobin concentrations, and muscle ﬁ  ber type to 
further elucidate what may cause such a varied response in 
%StO2 values. 
Summary
Even though we attempted to match our participants for 
age, gender, BMI, and activity levels, our results indicate 
that the control participants had higher exercise capacities 
and greater lung function than the COPD participants as 
was evidenced by the VO2 data, exercise workloads, and 
the inability of 2 COPD participants to complete 6 min of 
constant load exercise. Control participants and persons 
with COPD had similar levels of %StO2 during exercise 
in our study. This suggests that COPD pathology does 
not cause muscle dysfunction in terms of impaired muscle 
oxygenation in persons with moderate COPD. It is con-
cluded that peripheral skeletal muscle oxygenation is not 
compromised in individuals with moderate COPD during 
submaximal aerobic exercise, and that limitations in exer-
cise capacity are most likely a result of muscle disuse and 
poor lung function.International Journal of COPD 2006:1(4) 475
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